You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

LIDEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lidex patents expire, and when can generic versions of Lidex launch?

Lidex is a drug marketed by Alvogen and is included in three NDAs.

The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lidex

A generic version of LIDEX was approved as fluocinonide by COSETTE on December 2nd, 1988.

  Try a Trial

US Patents and Regulatory Information for LIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alvogen LIDEX-E fluocinonide CREAM;TOPICAL 016908-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alvogen LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alvogen LIDEX fluocinonide SOLUTION;TOPICAL 018849-001 Apr 6, 1984 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LIDEX

See the table below for patents covering LIDEX around the world.

Country Patent Number Title Estimated Expiration
Switzerland 516312 Arneimittelgrundlage zur lokalen Anwendung therapeutischer Wirkstoffe ⤷  Try a Trial
Netherlands 7114957 ⤷  Try a Trial
Japan S5410613 ⤷  Try a Trial
Austria 310948 ⤷  Try a Trial
Israel 37614 ⤷  Try a Trial
Belgium 774489 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.